Tilray Brands (NASDAQ:TLRY) Insider Acquires $11,950.00 in Stock

Tilray Brands, Inc. (NASDAQ:TLRY) insider Denise Faltischek bought 2,500 shares of the company’s stock in a transaction that occurred on Monday, August 3rd. The stock was purchased at an average price of $4.78 per share, for a total transaction of $11,950.00. Following the acquisition, the insider owned 141,285 shares of the company’s stock, valued at $675,342.30. This trade represents a 1.80% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Tilray Brands Stock Performance

Shares of Tilray Brands stock opened at $4.44 on Friday. The company has a current ratio of 2.21, a quick ratio of 1.37 and a debt-to-equity ratio of 0.22. The business has a 50-day moving average price of $4.60 and a two-hundred day moving average price of $6.09. Tilray Brands, Inc. has a 1-year low of $3.67 and a 1-year high of $23.20. The company has a market cap of $517.48 million, a P/E ratio of -4.11 and a beta of 1.90.

Tilray Brands (NASDAQ:TLRY) last announced its quarterly earnings data on Tuesday, July 28th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.42). Tilray Brands had a negative net margin of 13.11% and a negative return on equity of 7.76%. The business had revenue of $281.71 million during the quarter, compared to analyst estimates of $246.30 million. As a group, analysts anticipate that Tilray Brands, Inc. will post -0.4 EPS for the current year.

Institutional Trading of Tilray Brands

Large investors have recently made changes to their positions in the company. Hilton Head Capital Partners LLC acquired a new stake in Tilray Brands in the 4th quarter valued at $38,000. Pictet Asset Management Holding SA increased its stake in Tilray Brands by 38.9% during the 1st quarter. Pictet Asset Management Holding SA now owns 18,387 shares of the company’s stock valued at $119,000 after purchasing an additional 5,145 shares in the last quarter. Schonfeld Strategic Advisors LLC raised its holdings in Tilray Brands by 4.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 144,358 shares of the company’s stock worth $1,304,000 after buying an additional 6,182 shares during the last quarter. Baader Bank Aktiengesellschaft raised its holdings in Tilray Brands by 17.7% during the first quarter. Baader Bank Aktiengesellschaft now owns 47,938 shares of the company’s stock worth $293,000 after buying an additional 7,226 shares during the last quarter. Finally, IFP Advisors Inc lifted its stake in shares of Tilray Brands by 14.3% in the fourth quarter. IFP Advisors Inc now owns 60,318 shares of the company’s stock valued at $545,000 after buying an additional 7,541 shares in the last quarter. 9.35% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Wall Street Zen lowered Tilray Brands from a “hold” rating to a “sell” rating in a research note on Saturday, August 1st. TD Securities raised shares of Tilray Brands to a “strong-buy” rating in a research report on Friday, July 31st. Weiss Ratings lowered shares of Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 13th. Finally, TD Cowen dropped their target price on shares of Tilray Brands from $7.00 to $5.00 and set a “buy” rating on the stock in a research report on Tuesday, July 14th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $11.00.

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.